The fluoroquinoline compound exerts anti-erythroleukemic effects by dual-targeting GLUT1 and the PI3K/AKT signaling pathway

Abstract Erythroleukemia is a rare hematological malignancy in clinical practice, and currently, there are no effective treatment options other than stem cell transplantation. The study found that the fluoroquinoline compound FKL-137 can significantly inhibit the proliferation of erythroleukemia cel...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Sha Cheng, Weijia Zhao, Jia Yu, Xueling Meng, Bixue Xu, Ningning Zan, Baofei Sun, Heng Luo
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Nature Portfolio 2026-03-01
coleção:	Scientific Reports
Assuntos:	Fluoroquinoline Erythroleukemia GLUT1 PI3K/AKT Glucose metabolism Glycolysis
Acesso em linha:	https://doi.org/10.1038/s41598-026-45597-9
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!